Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer

HIGHLIGHTS

• who: Milja Reijonen from the We retrospectively reviewed consecutive epithelial OC patients who had been treated with NACT at Kuopio University Hospital, Finland, between , and We included patients with histopathologically confirmed primary OCs (tissue material collected through an ultrasound-guided needle biopsy or a surgical procedure before proceeding to NACT) who were treated with platinum-based NACT prior to the IDS attempt, and who had been imaged with mMRI after NACT. The permit for the use of patient register data for research purposes was issued by the Chief Medical Officer of the have published the Article: Neoadjuvant . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.